Identifying high-risk patients with MALT lymphoma undergoing first-line therapy for disease progression
Existing prognostic scoring systems for MALT lymphoma each have their own merit and are valuable for informing risk assessment in both clinical and research contexts, however, as understanding of the molecular and genetic drivers of MALT lymphomas improves and first-line treatment approaches incorporate novel targeted and immune-based therapies, there will likely be opportunities to enhance the current prognostic models.
Authors
- John Graham Sharp (ORCID: https://orcid.org/0000-0003-3023-8063)
- Adam J. Olszewski (ORCID: https://orcid.org/0000-0002-6472-6658)
- Narendranath Epperla (ORCID: https://orcid.org/0000-0002-8216-3457)
Institutions
- John Brown University (US)
- University of Utah (US)
- Brown University (US)
- The Ohio State University (US)
Publication Details
- Journal
- Expert Review of Hematology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1080/17474086.2025.2547834
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute